【先声药业(02096.HK):抗失眠症药物科唯可®获国家药品监督管理局批准在中国上市】智通财经APP讯,先声药业(02

智通财经
20 Jun
【先声药业(02096.HK):抗失眠症药物科唯可®获国家药品监督管理局批准在中国上市】智通财经APP讯,先声药业(02096.HK)发布公告,于2025年6月20日,集团与 Idorsia Pharmaceuticals Ltd.(dorsia)合作的抗失眠症药物科唯可® (盐酸达利雷生片)获中国国家药品监督管理局(NMPA)批准在中国上市,用于治疗以入睡困难和╱或睡眠维持困难为特征的成人失眠患者,且未被作为精神药品管制。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10